ESR1 and breast carcinoma: On the other hand, Chen et al. reported that NR inhibited proliferation, migration, and invasion of human metastatic estrogen receptor positive breast cancer cells by inactivating IL-6/STAT3-mediated EMT signaling pathways in vitro and in vivo (35).